Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic<i>TMPRSS2:ERG</i>fusion status
Manuel Luedeke(Universität Ulm), Christiane Maier(University of Utah), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust), Teuvo L.J. Tammela(Tampere University), Antje E. Rinckleb(Universität Ulm), Kathleen Herkommer(TUM Klinikum), Frank McCarthy(Chan Zuckerberg Initiative (United States)), Sandra E. Edwards(Institute of Cancer Research), Mark A. Rubin(University of Bern), Cármen Jerónimo(Universidade do Porto), Verena Lieb(Universitätsklinikum Erlangen), Elaine A. Ostrander(National Institutes of Health), Chee Goh(Institute of Cancer Research), Walther Vogel(Universität Ulm), Josef Hoegel(Universität Ulm), Manuel R. Teixeira(Instituto Português de Oncologia Francisco Gentil), Ali Amin Al Olama(Institute of Cancer Research), Zsofia Kote‐Jarai(Institute of Cancer Research), Sven Wach(Friedrich-Alexander-Universität Erlangen-Nürnberg), Lisa Cannon‐Albright(University of Utah), Rui Henrique(Universidade do Porto), Penny Flohr(Royal Marsden NHS Foundation Trust), Sven Perner(University Hospital Bonn), Hans Krause(Charité - Universitätsmedizin Berlin), Archana M. Agarwal(University of Utah), Johanna Schleutker(University of Turku), Sara Benlloch(Institute of Cancer Research), Katri A. Leinonen(Tampere University Hospital), Tiina Wahlfors, Tapio Visakorpi(Tampere University Hospital), Tilman T. Rau(University of Bern), Chris Parker(Royal Marsden NHS Foundation Trust), Matthias D. Hofer(Urology San Antonio), Colin S. Cooper(University of East Anglia), Janet L. Stanford(Fred Hutch Cancer Center), Milan S. Geybels(Fred Hutch Cancer Center), Steffen Weikert(St. Hedwig-Krankenhaus), Doug Easton(University of Cambridge), Rainer Kuefer(Alb Fils Kliniken), Paula Paulo(Universidade do Porto), Liesel M. FitzGerald
Cited by 12
Related Papers
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
|New England Journal of Medicine|2013|3.3k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k